alacepril has been researched along with Diabetic Nephropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, Y; Inoue, D; Koshiyama, H; Maeda, S; Sakaguchi, H | 1 |
| Matsubara, M; Saito, T; Taguma, Y; Yoshinaga, K | 1 |
| Hashimoto, T | 1 |
1 trial(s) available for alacepril and Diabetic Nephropathies
| Article | Year |
|---|---|
Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Blood Coagulation; Captopril; Diabetic Nephropathies; Drug Therapy, Combination; Esters; Female; Gabexate; Guanidines; Humans; Male; Middle Aged; Protease Inhibitors; Proteinuria; Uremia | 1992 |
2 other study(ies) available for alacepril and Diabetic Nephropathies
| Article | Year |
|---|---|
Hypoglycemia associated with the administration of angiotensin-converting enzyme inhibitor in a patient with diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Hypoglycemia; Middle Aged | 1997 |
[Treatment of latent diabetic nephropathy with ACE inhibitor alacepril].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; beta 2-Microglobulin; Captopril; Creatinine; Diabetic Nephropathies; Drug Evaluation; Female; Humans; Kidney; Male; Middle Aged | 1991 |